Think It's Too Late to Buy Tempus AI Stock? Here's the Biggest Reason Why There's Still Time.
Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...
Tempus AI, Inc. (TEM): Among the Health Information Services Stocks Outpacing the Market in 2025
We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...
Nasdaq1mon
Tempus AI teams with Genialis to develop RNA-based biomarker algorithms
Tempus AI (TEM), announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based ...
Tempus AI director David Epstein sells $19,724 in stock
David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 370 shares of the company's Class A Common Stock. The shares were sold on February 3, 2025, at an average price of $53.31 ...